BODIPY Ligand Metal Complexes for Deep Red OLED Emission
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organic light-emitting diodes (OLEDs) face limitations in achieving deep red to near-infrared emission, which is essential for advanced display technologies and lighting applications, as existing phosphorescent metal complexes do not efficiently emit in this spectral range.
Innovation Solution
Development of novel ligands based on pyridine, pyrimidine, pyrazine, quinoline, and quinoxaline derivatives substituted with boron-dipyrromethene (BODIPY), which induce a bathochromic shift in the emission of metal complexes, enabling deep red to near-infrared emission.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional phosphorescent metal complexes are used in OLEDs, then the device structure and fabrication process are relatively simple, but the emission spectrum is limited and cannot achieve deep red to near-infrared range
Solution Approach 1:
The patent employs composite ligand structures combining pyridine/pyrimidine/pyrazine cores with BODIPY fluorophores. This composite approach integrates the metal-coordinating ability of heterocyclic bases with the extended conjugation and red-shifted emission of BODIPY, achieving deep red to near-infrared emission while maintaining phosphorescent functionality through metal complexation.
Solution Approach 2:
The patent systematically varies structural parameters of the ligands including substitution patterns (2-, 4-, 5-positions), heteroatom composition (N, O, S), and BODIPY substitution types to tune the emission wavelength. This parameter optimization enables precise control over the emission spectrum to achieve the desired deep red to near-infrared range.
2Reliability
If existing OLED materials are used, then fabrication cost and process are lower, but performance in deep red to near-infrared emission is insufficient
Solution Approach 1:
The ligand synthesis is divided into modular stages: first constructing the heterocyclic core (pyridine, pyrimidine, or pyrazine), then introducing BODIPY units through controlled coupling reactions. This segmentation allows independent optimization of each fragment's properties and simplifies the overall synthesis pathway despite the complexity of the final structure.
Solution Approach 2:
The patent uses standardized intermediate compounds such as 2,4-dichloro-5-nitropyridine and various BODIPY precursors that can be coupled through well-established organic synthesis methods. These intermediary compounds serve as building blocks that bridge simple starting materials and the complex final ligand structures, making the synthesis more accessible.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of these novel ligands in OLEDs results in materials that emit light in the deep red to near-infrared regime, enhancing the performance and versatility of OLEDs for various applications, including advanced displays and lighting.
Implementation Method 1
substituted with a derivative of boron-dipyrromethene (BODIPY) which induces bathochromic shift of the emission of the synthesized metal complexes
Implementation Method 2
One application for phosphorescent emissive molecules is a full color display
Implementation Method 3
OLEDs make use of thin organic films that emit light when voltage is applied across the device
Data Source
AI summary
A neutral compound including a first ligand LA represented by Formula Ior Formula IIis disclosed.